Riluzole

References

• The pharmacology and mechanism of action of riluzole
  • A. Doble, Neurology 1996, 47, 233S.
• Riluzole: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis
  • H. M. Bryson, B. Fulton, P. Benfield, Drugs 1996, 52, 549.
• Riluzole Series. Synthesis and in Vivo "Antiglutamate" Activity of 6-Substituted-2-benzothiazolamines and 3-Substituted-2-imino-benzothiazolines
  • P. Jimonet, F. Audiau, M. Barreau, J.-C. Blanchard, A. Boireau, Y. Bour, M.-A. Coléno, A. Doble, G. Doerflinger, C. D. Huu , M.-H. Donat, J. M. Duchesne, P. Ganil, C. Guérémy, E. Honoré, B. Just, R. Kerphirique, S. Gontier, P. Hubert, P. M. Laduron, J. L. Blevec, M. Meunier, J.-M. Miquet, C. Nemecek, M. Pasquet, O. Piot, J. Pratt, J. Rataud, M. Reibaud, J.-M. Stutzmann, S. Mignani, J. Med. Chem. 1999, 42, 2828.
• Riluzole, neuroprotection and amyotrophic lateral sclerosis (a review)
  • B. C. Cheah, S. Vucic, A. V. Krishna, M. C. Kiernan, Curr. Med. Chem. 2010, 17, 1942.
• A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? (a review)
  • M. C. Bellingham, CNS Neurosci. Ther. 2011, 17, 4.